AbbVie said on Monday that it will launch ovarian cancer drug Elahere in the UK at the same list price as in the US. The announcement...
GENinCode shares rose 6 per cent on Thursday after University College London Hospitals (UCLH) became the first NHS trust to introduce its ovarian cancer test. The...
New research has identified a genomic signature that makes it possible to anticipate which patients with HR+/HER2- breast cancer will respond less well to CDK4/6 inhibitors. ...
Women who miss their first mammogram face a 40 per cent higher risk of dying from breast cancer over 25 years, mainly because cancers are detected...
Femtech World explores the latest business and investment developments in the world of women’s health. Funding supports US launch of world’s first AI-powered, automated IVF lab...
Women in their 80s who had regular mammograms showed a 74 per cent lower risk of dying from breast cancer compared with those who did not...
A cooling wristband device was found to reduce severe hot flash episodes by 46 per cent in breast cancer patients, prostate cancer patients and postmenopausal women,...
Campaigners are urging menopause support to be included in cancer treatment plans after a survey found 90 per cent of patients were given no guidance. The...
HIV research has identified a new target for ovarian cancer by selectively blocking a cleft in the retinoblastoma protein that protects tumour-supporting macrophages. The discovery could...
The financial impact of breast cancer on the UK economy is projected to rise by nearly a third to £4.2bn within 25 years, new analysis warns....
